Related Experiment Video
Updated: May 8, 2026

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
Published on: January 6, 2023
Jumping translocation in a case of de novo infant acute myeloid leukemia
Mayur Parihar1, Anurag Gupta, Anil Kumar Yadav
1Department of Cytogenetics and Laboratory Hematology, Tata Medical Center, Kolkata, India.
Insights
A rare jumping translocation (JT) on chromosome 1 was found in an infant with acute myeloid leukemia (AML). This genetic abnormality may play a key role in causing infant AML, not just its progression.
Area of Science:
- Genetics
- Pediatric Oncology
- Hematology
Background:
- Acute myeloid leukemia (AML) in infants is rare and often associated with complex genetic alterations.
- Jumping translocations (JT) are uncommon chromosomal rearrangements, and their role in pediatric AML is not fully understood.
Observation:
- An infant presented with symptoms including fever, ear discharge, proptosis, and hepatosplenomegaly.
- Diagnostic workup revealed acute monoblastic leukemia through bone marrow morphological and flowcytometric analysis.
Findings:
- Karyotyping identified a jumping translocation (JT) involving chromosome 1 as the sole cytogenetic abnormality in the infant's leukemia cells.
- The patient's condition rapidly progressed, leading to death within two months of diagnosis.
Implications:
- The presence of JT as the sole abnormality in de novo infant AML suggests a potential role in leukemogenesis.
- This finding challenges previous notions that JT is exclusively involved in tumor progression, highlighting its possible role as an initiating event in infant leukemia.
Abstract:
An infant presented with fever and purulent discharge from the left ear, proptosis of the right eye, and hepatosplenomegaly. She was diagnosed with acute monoblastic leukemia on morphological and flowcytometric analysis of the bone marrow. Karyotyping showed a jumping translocation (JT) involving the long arm of chromosome 1 as the sole cytogenetic abnormality in 29 metaphases. The patient died within 2 months of diagnosis. The presence of JT in a de novo infant AML as a sole cytogenetic abnormality indicates its possible role in leukemogenesis unlike previous reports that have implicated its role in tumor progression only.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Overview of Transposition and Recombination
Differentiation of Common Myeloid Progenitor Cells

